Stock listing
A2H8SU Stock Price, News, Filings & Events — Advicenne Sa
Selected listing: A2H8SU · LS · EUR · DE
This page tracks Advicenne Sa's A2H8SU:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2H8SU:LS. A2H8SU:LS is the stock-level entry point for investors researching Advicenne Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2H8SU:LS
- Asset type
- Stock
- Market cap
- $14.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Generic
- Exchange
- LS
- Currency
- EUR
Advicenne Sa A2H8SU:LS stock context
This page tracks Advicenne Sa's A2H8SU:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2H8SU:LS. A2H8SU:LS is the stock-level entry point for investors researching Advicenne Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Advicenne Sa
Advicenne decides to withdraw its ADV7103 New Drug Application in the USA
August 31, 2026
Advicenne Announces the Reimbursement of Sibnayal® for the Treatment of dRTA in Spain
July 20, 2026
Advicenne: Net Revenue for the First Half of 2026 Driven by Reimbursement of Sibnayal® and Likozam® in France
July 16, 2026
Advicenne Announces the Unlimited Renewal of the Marketing Authorization for Sibnayal® in the United Kingdom
July 1, 2026
Advicenne secures its cash runway to Q2 2027 through a bond financing of a nominal amount of up to EUR3.8 million
June 23, 2026
Research Advicenne Sa
Advicenne Sa investor report
Review AI stock analysis and investor report context for A2H8SU:LS.
Advicenne Sa company profile
View the public company page for Advicenne Sa on 6ix.
Advicenne Sa news
Read company news and market updates connected to Advicenne Sa.
Advicenne Sa investor events
Find investor webinars, events, and replay context for Advicenne Sa.
Alternate listings
ALDVI:EURONEXT
FR · EUR
Alternate listing for Advicenne Sa; the primary context on this page is A2H8SU:LS.
3MM:GETTEX
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is A2H8SU:LS.
A2H8SU:LSX
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is A2H8SU:LS.
3MM:FWB
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is A2H8SU:LS.
3MM:DUS
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is A2H8SU:LS.
3MM:MUN
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is A2H8SU:LS.
ADVVF:OTC
US · USD
Alternate listing for Advicenne Sa; the primary context on this page is A2H8SU:LS.
3MM:SWB
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is A2H8SU:LS.